Efficacy of Omalizumab in Mastocytosis: Allusive Indication Obtained from a Prospective, Double-Blind, Multicenter Study (XOLMA Study).
Dermatology
; 236(6): 529-539, 2020.
Article
in En
| MEDLINE
| ID: mdl-31958790
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Anti-Allergic Agents
/
Mastocytosis, Systemic
/
Omalizumab
Type of study:
Clinical_trials
/
Observational_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Dermatology
Journal subject:
DERMATOLOGIA
Year:
2020
Document type:
Article